Magnite, Inc. MGNI
15 insiders sold $29.5M on the market, none bought
Form 4Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.
A year of insider trades, day by day
Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025
$0 bought on 0 days, $29.6M sold on 31 days. Each square is a day; click one for its Form 4.
Buys and sales by insider
Who traded · Form 4, added up
| Insider | Bought | Sold | Latest |
|---|---|---|---|
| Michael G. Barrett CEO, Director |
- | $13.6M | Aug 6, 2026 |
| Sean Patrick Buckley See Remarks |
- | $3.0M | Nov 5, 2026 |
| Douglas S. Knopper Director |
- | $2.7M | Sep 17, 2026 |
| Katie Seitz Evans See Remarks |
- | $2.6M | Nov 9, 2026 |
| James Rossman Director |
- | $1.4M | Nov 11, 2026 |
| Aaron Saltz CHIEF LEGAL OFFICER |
- | $1.2M | Nov 9, 2026 |
| Sarah Patricia Harden Director |
- | $1.2M | Aug 28, 2026 |
| Paul Caine Director |
- | $1.0M | Oct 12, 2026 |
| David Buonasera CHIEF TECHNOLOGY OFFICER |
- | $1.0M | Nov 9, 2026 |
| Diane Yu Director |
- | $583K | Nov 12, 2026 |
| Brian Gephart CHIEF FINANCIAL OFFICER |
- | $414K | Nov 9, 2026 |
| Robert F. Spillane Director |
- | $246K | Sep 14, 2026 |
| Rachel Lam Director |
- | $242K | Aug 10, 2026 |
| David T. Pearson Director |
- | $168K | Jun 10, 2026 |
| Haas Sullivan CHIEF ACCOUNTING OFFICER |
- | $72K | Nov 11, 2026 |
Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.
Trade by trade, newest first
Every trade · each date links to its Form 4
Of 54 open-market sales by officers and directors, 5 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | Diane Yu | Sale | -20,000 | 583K |
| Nov 11, 2026 | James Rossman | Sale | -49,190 | 1.4M |
| Nov 11, 2026 | Haas Sullivan | Sale | -2,427 | 72K |
| Nov 9, 2026 | Katie Seitz Evans | Sale | -26,178 | 758K |
| Nov 9, 2026 | Brian Gephart | Sale | -3,700 | 106K |
| Nov 9, 2026 | Aaron Saltz | Sale | -9,597 | 276K |
| Nov 9, 2026 | David Buonasera | Sale (10b5-1) | -871 | 25K |
| Nov 5, 2026 | Sean Patrick Buckley | Sale (10b5-1) | -10,991 | 297K |
| Nov 5, 2026 | David Buonasera | Sale (10b5-1) | -4,272 | 115K |
| Nov 5, 2026 | David Buonasera | Sale (10b5-1) | -1,434 | 40K |
| Oct 12, 2026 | Paul Caine | Sale (10b5-1) | -12,500 | 316K |
| Sep 17, 2026 | Douglas S. Knopper | Sale (10b5-1) | -37,337 | 981K |
| Sep 17, 2026 | Paul Caine | Sale (10b5-1) | -7,500 | 199K |
| Sep 14, 2026 | Robert F. Spillane | Sale | -10,363 | 246K |
| Sep 14, 2026 | David Buonasera | Sale (10b5-1) | -1,165 | 28K |
| Sep 11, 2026 | Katie Seitz Evans | Sale (10b5-1) | -13,997 | 336K |
| Sep 10, 2026 | Paul Caine | Sale (10b5-1) | -5,000 | 118K |
| Sep 10, 2026 | Aaron Saltz | Sale (10b5-1) | -40,000 | 936K |
| Sep 9, 2026 | Katie Seitz Evans | Sale (10b5-1) | -11,100 | 260K |
| Sep 8, 2026 | Katie Seitz Evans | Sale (10b5-1) | -32,285 | 763K |
| Sep 2, 2026 | David Buonasera | Sale (10b5-1) | -1,043 | 26K |
| Sep 1, 2026 | David Buonasera | Sale (10b5-1) | -5,371 | 126K |
| Aug 28, 2026 | Sarah Patricia Harden | Sale (10b5-1) | -18,436 | 442K |
| Aug 26, 2026 | Sarah Patricia Harden | Sale (10b5-1) | -30,550 | 712K |
| Aug 18, 2026 | Sean Patrick Buckley | Sale (10b5-1) | -2,759 | 69K |
| Aug 17, 2026 | Sean Patrick Buckley | Sale (10b5-1) | -8,271 | 201K |
| Aug 14, 2026 | Paul Caine | Sale (10b5-1) | -7,500 | 188K |
| Aug 10, 2026 | Paul Caine | Sale (10b5-1) | -5,000 | 122K |
| Aug 10, 2026 | Rachel Lam | Sale | -10,000 | 242K |
| Aug 10, 2026 | Brian Gephart | Sale | -12,479 | 308K |
| Aug 6, 2026 | Michael G. Barrett | Sale (10b5-1) | -293,968 | 6.7M |
| Aug 6, 2026 | Douglas S. Knopper | Sale (10b5-1) | -37,337 | 848K |
| Aug 6, 2026 | Katie Seitz Evans | Sale (10b5-1) | -20,000 | 480K |
| Aug 6, 2026 | Sean Patrick Buckley | Sale (10b5-1) | -47,942 | 1.2M |
| Aug 6, 2026 | Sean Patrick Buckley | Sale (10b5-1) | -19,237 | 442K |
| Aug 6, 2026 | David Buonasera | Sale (10b5-1) | -4,176 | 95K |
| Aug 6, 2026 | David Buonasera | Sale (10b5-1) | -2,602 | 62K |
| Aug 6, 2026 | David Buonasera | Sale (10b5-1) | -871 | 22K |
| Jul 15, 2026 | Michael G. Barrett | Sale (10b5-1) | -38,596 | 785K |
| Jul 10, 2026 | Paul Caine | Sale (10b5-1) | -5,000 | 103K |
| Jul 7, 2026 | Sean Patrick Buckley | Sale (10b5-1) | -19,233 | 404K |
| Jul 7, 2026 | David Buonasera | Sale (10b5-1) | -1,224 | 26K |
| Jul 1, 2026 | David Buonasera | Sale (10b5-1) | -9,376 | 188K |
| Jun 29, 2026 | Michael G. Barrett | Sale (10b5-1) | -75,000 | 1.5M |
| Jun 17, 2026 | David Buonasera | Sale (10b5-1) | -1,409 | 27K |
| Jun 17, 2026 | Sean Patrick Buckley | Sale (10b5-1) | -19,233 | 365K |
| Jun 16, 2026 | Michael G. Barrett | Sale (10b5-1) | -100,000 | 1.8M |
| Jun 16, 2026 | David Buonasera | Sale (10b5-1) | -11,233 | 202K |
| Jun 16, 2026 | Douglas S. Knopper | Sale (10b5-1) | -37,337 | 676K |
| Jun 15, 2026 | Michael G. Barrett | Sale (10b5-1) | -178,596 | 3.0M |
| Jun 15, 2026 | David Buonasera | Sale (10b5-1) | -1,057 | 18K |
| Jun 10, 2026 | David T. Pearson | Sale (10b5-1) | -10,766 | 168K |
| Jun 10, 2026 | Douglas S. Knopper | Sale (10b5-1) | -10,766 | 169K |
| Jun 1, 2026 | David Buonasera | Sale (10b5-1) | -1,409 | 21K |
Show the other 39 trades
Sources
Form 4s from SEC's filing index. An insider files one within two business days of a trade.
Also
Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MGNI/export.csv") into a cell.